{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:41:12Z","timestamp":1762252872486,"version":"3.41.2"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006812","name":"Center for Integrated Healthcare, U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"DOI":"10.3389\/fvets.2018.00285","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T08:37:54Z","timestamp":1542616674000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Endochin-Like Quinolones Exhibit Promising Efficacy Against Neospora Caninum in vitro and in Experimentally Infected Pregnant Mice"],"prefix":"10.3389","volume":"5","author":[{"given":"Nicoleta","family":"Anghel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vreni","family":"Balmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Winzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Aguado-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Roozbehani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sovitj","family":"Pou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Riscoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Stone","family":"Doggett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hemphill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,19]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1201\/9781315152561","volume-title":"Neosporosis in Animals","author":"Dubey","year":"2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/S0020-7519(98)00138-6","article-title":"Dogs are definitive hosts of Neospora caninum","volume":"28","author":"McAllister","year":"1998","journal-title":"Int J Parasitol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.ijpara.2010.01.008","article-title":"Australian dingoes are definitive hosts of Neospora caninum","volume":"28","author":"King","year":"2010","journal-title":"Int J Parasitol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.vetpar.2011.05.018","article-title":"Gray wolf (Canis lupus) is a natural definitive host for Neospora caninum","volume":"181","author":"Dubey","year":"2011","journal-title":"Vet Parasitol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ijpara.2004.01.001","article-title":"Coyotes (Canis latrans) are definitive hosts of Neospora caninum","volume":"34","author":"Gondim","year":"2004","journal-title":"Int J Parasitol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ijpara.2017.09.002","article-title":"ApiCOWplexa 2017\u22124th International meeting on apicomplexan parasites in farm animals","volume":"47","author":"Hemphill","year":"2017","journal-title":"Int J Parasitol"},{"volume-title":"Toxoplasmosis of Animals and Humans.","year":"2010","author":"Dubey","key":"B7"},{"key":"B8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.exppara.2014.02.015","article-title":"Vaccines against neosporosis: what can we learn from the past studies?","volume":"140","author":"Monney","year":"2014","journal-title":"Exp Parasitol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/pim.12342","article-title":"Vaccines for bovine neosporosis: current status and key aspects for development","volume":"38","author":"Horcajo","year":"2016","journal-title":"Parasit Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ijpara.2017.09.001","article-title":"Neospora caninum in non pregnant and pregnant mouse models: cross-talk between infection and immunity","volume":"47","author":"Aguado-Mart\u00ednez","year":"2017","journal-title":"Int J Parasitol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/S0031182015001596","article-title":"Approaches for the vaccination and treatment of Neospora caninum infections in mice and ruminant models","volume":"143","author":"Hemphill","year":"2016","journal-title":"Parasitol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"Andrews","year":"2014","journal-title":"Int J Parasitol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/17460441.2016.1195945","article-title":"Drug target identification in protozoan parasites","volume":"11","author":"M\u00fcller","year":"2016","journal-title":"Exp Opin Drug Discov"},{"key":"B14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.exppara.2007.10.016","article-title":"Antimalarial quinolones: synthesis, potency, and mechanistic studies","volume":"118","author":"Winter","year":"2008","journal-title":"Exp Parasitol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature05572","article-title":"Specific role of mitochondrial electron transport in bloodstage Plasmodium falciparum","volume":"446","author":"Painter","year":"2007","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"15936","DOI":"10.1073\/pnas.1208069109","article-title":"Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis","volume":"109","author":"Doggett","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1126\/scitranslmed.3005029","article-title":"Quinolone-3-diarylethers: a new class of antimalarial drug","volume":"5","author":"Nilsen","year":"2015","journal-title":"Sci Transl Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1128\/AAC.04149-14","article-title":"Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum","volume":"59","author":"Stickles","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/1873-3468.13035","article-title":"The antimalarial compound ELQ-400 is an unusual inhibitor of the bc(1) complex, targeting both Q(o) and Q(i) sites","volume":"592","author":"Song","year":"2018","journal-title":"FEBS Lett"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.8b00133.","article-title":"Targeted structure-activity analysis of endochin-like quinolones reveals potent Qi and Qo Site inhibitors of Toxoplasma gondii and Plasmodium falciparum cytochrome bc(1) and Identifies ELQ-400 as a remarkably effective compound against acute experimental toxoplasmosis","author":"McConnell","year":"2018","journal-title":"ACS Infect Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1128\/AAC.01183-15","article-title":"ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria","volume":"59","author":"Miley","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.exppara.2010.10.016","article-title":"Optimization of endochin-like quinolones for antimalarial activity","volume":"127","author":"Winter","year":"2011","journal-title":"Exp Parasitol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1128\/AAC.01866-16","article-title":"Genetic evidence for cytochrome b Qi site inhibition by 4(1H)-quinolone-3 diarylethers and antimycin","volume":"24","author":"Alday","year":"2017","journal-title":"Toxoplasma gondii. Antimicrob Agents Chemother"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1084\/jem.20151519","article-title":"Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone","volume":"213","author":"Lawres","year":"2016","journal-title":"J Exp Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1128\/AAC.01236-15","article-title":"In vitro and in vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans Toxoplasma gondii and Neospora caninum","volume":"59","author":"Winzer","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13567-016-0317-1","article-title":"Repurposing of antiparasitic drugs: the hydroxy-naphthoquinone buparvaquone inhibits vertical transmission in the pregnant neosporosis mouse model","volume":"47","author":"M\u00fcller","year":"2016","journal-title":"Vet Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1017\/S0031182016000056","article-title":"N-terminal fusion of a toll-like receptor 2-ligand to a Neospora caninum chimeric antigen efficiently modifies the properties of the specific immune response","volume":"143","author":"Aguado-Mart\u00ednez","year":"2016","journal-title":"Parasitol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijpddr.2012.03.001","article-title":"Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice","volume":"2","author":"Schorer","year":"2012","journal-title":"Int J Parasitol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.1128\/AAC.02446-12","article-title":"In vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites","volume":"57","author":"Barna","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ijpara.2017.06.002","article-title":"In vitro screening of the open source Pathogen Box identifies novel compounds with profound activities against Neospora caninum","volume":"47","author":"M\u00fcller","year":"2017","journal-title":"Int J Parasitol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1017\/S0031182010000442","article-title":"Molecular characterization of Neospora caninum MAG1, a dense granule protein secreted into the parasitophorous vacuole, and associated with the cyst wall and the cyst matrix","volume":"137","author":"Guionaud","year":"2010","journal-title":"Parasitology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1017\/S0031182013000383","article-title":"Molecular cloning and characterization of NcROP2Fam-1, a member of the ROP2 family of rhoptry proteins in Neospora caninum that is targeted by antibodies neutralizing host cell invasion in vitro","volume":"140","author":"Alaeddine","year":"2013","journal-title":"Parasitology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.13653024.1998.00127.x","article-title":"Characterization of Neospora caninum iscom antigens using monoclonal antibodies","volume":"20","author":"Bjorkman","year":"1998","journal-title":"Parasite Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/pathogens2020193","article-title":"Use of a Th1 stimulator adjuvant for vaccination against Neospora caninum infection in the pregnant mouse model","volume":"2","author":"Monney","year":"2013","journal-title":"Pathogens"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ijpara.2009.04.006","article-title":"Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites","volume":"39","author":"Debache","year":"2009","journal-title":"Int J Parasitol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijpddr.2015.02.001","article-title":"Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice","volume":"5","author":"M\u00fcller","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"B37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1017\/S0031182009991259","article-title":"Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites","volume":"137","author":"Debache","year":"2010","journal-title":"Parasitol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6967","DOI":"10.1016\/j.vaccine.2011.07.038","article-title":"RecNcMIC3-1-R is a microneme- and rhoptry-based chimeric antigen that protects against acute neosporosis and limits cerebral parasite load in the mouse model for Neospora caninum infection","volume":"29","author":"Monney","year":"2011","journal-title":"Vaccine"},{"journal-title":"R: A Language and Environment For Statistical Computing","year":"2012","key":"B39"},{"key":"B40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.vetpar.2015.05.021","article-title":"Dose-dependent effects of experimental infection with the virulent Neospora caninum Nc-Spain7 isolate in a pregnant mouse model","volume":"2011","author":"Arranz-Sol\u00eds","year":"2015","journal-title":"Vet Parasitol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e02324","DOI":"10.1128\/AAC.02324-16","article-title":"Two novel calcium dependent protein kinase 1 inhibitors interfere with vertical transmission in mice infected with Neospora caninum Tachyzoites","volume":"61","author":"M\u00fcller","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"25","author":"Alday","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1056\/NEJMra1202018","article-title":"Human babesiosis","volume":"366","author":"Vannier","year":"2012","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1128\/AAC.02801-15","article-title":"In Vitro screening of the open-source medicines for malaria venture malaria box reveals novel compounds with profound activities against theileria annulata schizonts","volume":"60","author":"Hostettler","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1093\/jac\/dkx134","article-title":"Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis","volume":"72","author":"M\u00fcller","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e92929","DOI":"10.1371\/journal.pone.0092929","article-title":"Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy","volume":"9","author":"Ojo","year":"2014","journal-title":"PLoS ONE"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1002\/cmdc.201700600","article-title":"Activities of 11-Azaartemisinin and N-Sulfonyl derivatives against Neospora caninum and comparative cytotoxicities","volume":"12","author":"Harmse","year":"2017","journal-title":"Chem Med Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0031182018000975","article-title":"In vitro treatment of Besnoitia besnoiti with the naphto-quinone buparvaquone results in marked inhibition of tachyzoite proliferation, mitochondrial alterations and rapid adaptation of tachyzoites to increased drug concentrations","volume":"20","author":"M\u00fcller","year":"2018","journal-title":"Parasitology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s004360000306","article-title":"Efficacy of toltrazuril and ponazuril against experimental Neospora caninum infection in mice","volume":"87","author":"Gottstein","year":"2001","journal-title":"Parasitol Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00436-009-1328-x","article-title":"Toltrazuril treatment of congenitally acquired Neospora caninum infection in newborn mice","volume":"104","author":"Strohbusch","year":"2009","journal-title":"Parasitol Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1128\/AAC.00791-16","article-title":"Atovaquone and ELQ-300 combination therapy as a novel dual-site cytochrome bc1 inhibition strategy for malaria","volume":"60","author":"Stickles","year":"2016","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fvets.2018.00285\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T08:37:56Z","timestamp":1542616676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fvets.2018.00285\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,19]]},"references-count":51,"alternative-id":["10.3389\/fvets.2018.00285"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2018.00285","relation":{},"ISSN":["2297-1769"],"issn-type":[{"type":"electronic","value":"2297-1769"}],"subject":[],"published":{"date-parts":[[2018,11,19]]},"article-number":"285"}}